Literature DB >> 23556094

The bone marrow microenvironment in waldenstrom macroglobulinemia.

Irene M Ghobrial1, Patricia Maiso, Abdelkareem Azab, Yang Liu, Yong Zhang, Ghayas Issa, Feda Azab, Antonio Sacco, Phong Quang, Hai Ngo, Aldo Roccaro.   

Abstract

Waldenstrom macroglobulinemia (WM) is a low-grade B-cell lymphoproliferative disorder characterized primarily by specific homing and growth of tumor cells within the bone marrow niches. The progressive growth of tumor cells throughout the bone marrow indicates that the tumor cells are capable of homing and adhering to specific niches that allow growth, survival and drug resistance. In this review we highlight the interaction of the tumor cells in WM and the bone marrow microenvironment including bone marrow stromal cells, endothelial cells and mast cells. Migration, adhesion and downstream activation of signaling pathways leads to cell trafficking and cell dissemination in WM. Future therapeutic agents need to target not only the tumor clone, but also its close interaction with the bone marrow microenvironment.

Entities:  

Keywords:  Waldenstrom; adhesion; bone marrow; cell trafficking; homing; migration; niche

Year:  2011        PMID: 23556094      PMCID: PMC3573408          DOI: 10.1177/2040620711410096

Source DB:  PubMed          Journal:  Ther Adv Hematol        ISSN: 2040-6207


  49 in total

Review 1.  G protein coupled receptor signaling through the Src and Stat3 pathway: role in proliferation and transformation.

Authors:  P T Ram; R Iyengar
Journal:  Oncogene       Date:  2001-03-26       Impact factor: 9.867

Review 2.  Molecular targeting: PI3 kinase pathway.

Authors:  J E Dancey
Journal:  Ann Oncol       Date:  2004       Impact factor: 32.976

Review 3.  Exploiting the PI3K/AKT pathway for cancer drug discovery.

Authors:  Bryan T Hennessy; Debra L Smith; Prahlad T Ram; Yiling Lu; Gordon B Mills
Journal:  Nat Rev Drug Discov       Date:  2005-12       Impact factor: 84.694

4.  The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.

Authors:  A Peled; O Kollet; T Ponomaryov; I Petit; S Franitza; V Grabovsky; M M Slav; A Nagler; O Lider; R Alon; D Zipori; T Lapidot
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

5.  The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.

Authors:  R K Ganju; S A Brubaker; J Meyer; P Dutt; Y Yang; S Qin; W Newman; J E Groopman
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

6.  A SCID-hu in vivo model of human Waldenström macroglobulinemia.

Authors:  Pierfrancesco Tassone; Paola Neri; Jeffery L Kutok; Olivier Tournilhac; Daniel Ditzel Santos; Evdoxia Hatjiharissi; Vidit Munshi; Salvatore Venuta; Kenneth C Anderson; Steven P Treon; Nikhil C Munshi
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

7.  microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Xiaoying Jia; Abdel Kareem Azab; Patricia Maiso; Hai T Ngo; Feda Azab; Judith Runnels; Phong Quang; Irene M Ghobrial
Journal:  Blood       Date:  2010-06-02       Impact factor: 22.113

8.  SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia.

Authors:  Stéphanie Poulain; Marjan Ertault; Xavier Leleu; Valérie Coiteux; José Fernandes; Laure Stalnikiewicz; Patrick Duthilleul; Pierre Morel
Journal:  Leuk Res       Date:  2009-04-24       Impact factor: 3.156

Review 9.  SDF-1 and CXCR4 in normal and malignant hematopoiesis.

Authors:  J Juarez; L Bendall
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

Review 10.  Angiogenesis in Waldenström's macroglobulinemia.

Authors:  Evangelos Terpos; Anna Tasidou; Efstathios Kastritis; Evangelos Eleftherakis-Papaiakovou; Maria Gavriatopoulou; Magdalini Migkou; Meletios-Athanassios Dimopoulos
Journal:  Clin Lymphoma Myeloma       Date:  2009-03
View more
  2 in total

1.  Hematologic disorder-associated Cxcr4 gain-of-function mutation leads to uncontrolled extrafollicular immune response.

Authors:  Nagham Alouche; Amélie Bonaud; Vincent Rondeau; Rim Hussein-Agha; Julie Nguyen; Valeria Bisio; Mélanie Khamyath; Etienne Crickx; Niclas Setterblad; Nicolas Dulphy; Matthieu Mahevas; David H McDermott; Philip M Murphy; Karl Balabanian; Marion Espéli
Journal:  Blood       Date:  2021-06-03       Impact factor: 25.476

Review 2.  Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.

Authors:  Ava J Boutilier; Lina Huang; Sherine F Elsawa
Journal:  Int J Mol Sci       Date:  2022-09-22       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.